MRI scan to be trialed as a test for prostate cancer in the UK

Written by Jade Parker, Senior Editor

Men are set to be offered MRI scans as part of a clinical trial, which could lead to a national screening program in the UK for prostate cancer. The trial, termed ReIMAGINE, will assess whether MRI scans can be used as a population-based screening tool to detect prostate cancer, rather than the prostate-specific antigen (PSA) blood test, which is often unreliable. The trial constitutes of two parts, both of which are set to start in 2019. The first part is called ReIMAGINE Prostate Cancer risk, this study will recruit approximately 1000 men who have had a raised PSA test and have...

To view this content, please register now for access

It's completely free